Shanghai Henlius Biotech's statutory profit might not fully ...
Shanghai Henlius Biotech's statutory profit might not fully reflect the company's underlying earning capacity due to unusual item expense. The change from loss to profit is a positive turn for the firm.
Shanghai Henlius Biotech's (HKG:2696) Solid Earnings Are Supported By Other Strong Factors
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment